Patented Products 
  Oncology Formulations
  Therapeutic
    
Segments
 Oncology API
  Specialty API's
  Chiral intermediates
 
Chiral intermediates 
Chiral Synthesis has become important in research and Industry due to the need for increased pathways for identifying active enantiomers in the rascemic mixture. This leads to strong and fast growing range of new chiral building blocks, chiral catalysts and the increased use of chiral biotransformation in organic synthesis.
 
Monosaccharides Derivatives
Tartaric Acid Derivatives
1,2-Amino Alcohols
1,2-Amino Alcohols Oxazolidinones
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.